Synutra opens plants to inspection following ministry probe order

Milk formula producer Synutra (SYUT.NASDAQ) said its products were safe, but that it would open its plants for inspection following reports that its baby formula led to premature development in infants, Bloomberg reported. China’s health ministry had ordered a probe into the reports, which said that baby girls in Wuhan fed on Synutra formula had developed breasts and had abnormally high levels of the hormone estradiol in their bodies. Synutra quickly denied that its products were unsafe and threatened legal action to protect its brand. The company revealed that it purchased ingredients from New Zealand dairy firm Fonterra, France’s Euroserum and from Heilongijang province.